Selbyville, Delaware, June 01, 2020 (GLOBE NEWSWIRE) -- With inception in Wuhan in December of 2019, COVID-19 has rapidly spread across the globe. As the number of positive and suspected coronavirus cases multiply, the demand for COVID-19 diagnostic testing kits will also surge, depicting a golden phase for market growth. Global COVID-19 diagnostic testing industry is estimated to accumulate more than USD 44481 million in the year 2020, while the total number of COVID-19 tests is projected to reach 329.17 million. These tests are vital for the management of existing pandemic situation as they provide accurate diagnosis and enables in preventing the spread of the infection.
As per the report, the market has been categorized into segments based on test type, end-user, region, and country. Data with respect to industry share held by each segment and their individual revenue contribution is documented. The report delivers insights about the vaccine development and leading vaccine candidates. With an exhaustive documentation, the research aims to help regulatory authorities, investment banks & equity firms, government & policy makers, consulting & advisory firms, global healthcare agencies, pharmaceutical companies, and COVID-19 diagnostic test kit dealers, manufacturers, and suppliers to make informed decisions.
Request Sample copy of this Report @ https://www.marketstudyreport.com/request-a-sample/2679121/
Test type spectrum:
In terms of test type, worldwide COVID-19 diagnostic testing market is divided into serology tests and molecular tests. The latter segment is poised to gain substantial traction over the analysis timeframe, on account of undeterred emphasis towards development of COVID-19 symptomatic products. Public and private entities are backing molecular diagnostic organizations with heavy funding for fast-track discovery.
End-use landscape:
COVID-19 diagnostic testing market share from private or commercial labs is anticipated to record significant growth over 2020-2025. Surging pervasiveness of coronavirus has compelled the governments across the globe to involve public or commercial firms in order to amplify the testing capacity and address the immediate issue of pandemic.
Market players:
Taking into consideration the seriousness of this pandemic, World Health Organization (WHO) is encouraging healthcare institutes to emphasize on COVID-19 indicative testing. Companies like Chembio Diagnostics and Abbott are coming up with care commercial centers. Likewise, Cepheid received EUA (Emergency Use Authorization) from FDA (Food & Drug Administration) for POC test – Xpert® Xpress SARS-CoV-2 test in March 2020.
Healthcare majors are further undertaking different strategies to enhance their market stake. Citing an instance, Quest Diagnostics entered into a collaboration with Ortho Clinic Diagnostics in May 2020 to amplify COVID-19 antibody testing across 20 laboratories in the United States.
To access a sample copy or view this report in detail along with the table of contents, please click the link below:
Global COVID-19 Diagnostic Testing Market Test Type Analysis (Revenue, USD Million, 2020-2025)
- Serology Tests
- Molecular Tests
Global COVID-19 Diagnostic Testing Market End-user Analysis (Revenue, USD Million, 2020-2025)
- Private or Commercial Labs
- Public Health Labs
- Others
Global COVID-19 Diagnostic Testing Market Geographical Analysis (Revenue, USD Million, 2020-2025)
Americas
- Brazil
- Canada
- United States
Europe
- Russia
- Italy
- Spain
- United Kingdom
- France
- Germany
Asia Pacific
- Singapore
- South Korea
- India
- Japan
- China
Global COVID-19 Diagnostic Testing Market Competitive Landscape Analysis (Revenue, USD Million, 2020-2025)
- PerkinElmer
- Seegene
- BGI Genomics
- Cepheid
- Thermo Fisher Scientific
- Becton Dickinson
- Abbott Laboratories
- Siemens Healthineers
- Roche Holding AG
- BioMérieux
Table of content:
1. Report Scope and Methodology
1.1 Scope of the Report
1.2 Research Methodology
1.3 Executive Summary
2. Strategic Recommendations
3. Global COVID-19 Diagnostic Testing Market: Product Outlook
4. Global COVID-19 Diagnostic Testing Market: Sizing and Forecast
4.1 Market Size, By Value, Year 2020-2025
4.2 Market Size, By COVID-19 Tests, Year 2020-2025
5. Global COVID-19 Diagnostic Testing Market Segmentation By Test Type
5.1 Competitive Scenario of Global COVID-19 Diagnostic Testing: By Test Type
5.2 Molecular Tests a?? Market Size and Forecast (2020-2025)
5.3 Serology Tests a?? Market Size and Forecast (2020-2025)
6. Global COVID-19 Diagnostic Testing Market Segmentation By End-User
6.1 Competitive Scenario of Global COVID-19 Diagnostic Testing: By End-User
6.2 Public Health Labs a?? Market Size and Forecast (2020-2025)
6.3 Private or Commercial Labs - Market Size and Forecast (2020-2025)
6.4 Others - Market Size and Forecast (2020-2025)
7. Global COVID-19 Diagnostic Testing Market: Regional Analysis
7.1 Competitive Scenario of Global COVID-19 Diagnostic Testing: By Region, By Value
8. Americas COVID-19 Diagnostic Testing Market: Segmentation By Test Type, End-User (2020-2025)
9. Europe COVID-19 Diagnostic Testing Market: Segmentation By Test Type, End-User (2020-2025)
10. Asia Pacific COVID-19 Diagnostic Testing Market: Segmentation By Test Type, End-User (2020-2025)
10.1 Asia Pacific COVID-19 Diagnostic Testing Market: Size and Forecast (2020-2025), By Value
10.2 Asia Pacific COVID-19 Diagnostic Testing Market: Size and Forecast (2020-2025), By COVID-19 Tests
10.3 Asia Pacific COVID-19 Diagnostic Testing Market a?? Prominent Companies
10.4 Market Segmentation By Test Type (Molecular Tests, Serology Tests)
10.5 Market Segmentation By End-User (Public Health Labs, Private or Commercial Labs, Others)
11. Global COVID-19 Diagnostic Testing Market Dynamics
11.1 Global COVID-19 Diagnostic Testing Market Drivers
11.2 Global COVID-19 Diagnostic Testing Market Restraints
11.3 Global COVID-19 Diagnostic Testing Market Trends
12. COVID-19 Vaccine Development
12.1 Overview of Vaccine Development
12.2 Overview of the leading vaccine candidates
13. Competitive Landscape
14. Company Profiles (Business Description, Financial Analysis, Business Strategy)
Related Report:
Global Cardiac Biomarker Diagnostic Kits Market Size and Regional Forecasts 2020-2026
Global Cardiac Biomarker Diagnostic Kits Market is valued approximately USD 2.33 billion in 2019 and is anticipated to grow with a healthy growth rate of more than 5.4% over the forecast period 2019-2026; as per new research report. Cardiac Biomarker diagnostic kits is a subset of tools and instruments those are used to measure and evaluate heart functions. It has remarkable role in early prediction or diagnosis of heart related diseases. Therefore, increasing prevalence of cardiovascular diseases across the globe is the factor attributed to drive the growth of market over the forecast years. For instance: As per the World Health Organization, Cardiovascular diseases are estimated as the primary reason of death due to disease across the globe which accounts for over 17.9 million, 31% of worldwide death each year due to cardiovascular disease
About US:
Market Study Report, LLC. is a hub for market intelligence products and services.
We streamline the purchase of your market research reports and services through a single integrated platform by bringing all the major publishers and their services at one place.
Our customers partner with Market Study Report, LLC. to ease their search and evaluation of market intelligence products and services and in turn focus on their company's core activities.
If you are looking for research reports on global or regional markets, competitive information, emerging markets and trends or just looking to stay on top of the curve then Market Study Report, LLC. is the platform that can help you in achieving any of these objectives.